CCL4 and Burkitt lymphoma: Furthermore, at least in Burkitt’s lymphoma patients, CD56−CD16+ NK cells seem to retain MIP1β/CCL4 production, which can attract CCR5+ regulatory T and suppressive myeloid cell populations [92,93].